Clinical Trial: Heart and Vascular

Interrupt AF

Full Name

Prospective Evaluation of Open Irrigated Ablation Catheters With High Resolution Mapping to Treat Paroxysmal Atrial Fibrillation


Purpose: To assess outcomes for the Rhythmia Mapping System in conjunction with Boston Scientific Open-Irrigated Ablation Catheters to treat de novo Paroxysmal Atrial Fibrillation. De Novo PAF is defined as subjects undergoing first ablation procedure for PAF with no prior left atrial ablation


All subjects fitting the enrollment criteria, signing the consent and undergoing the procedure with the study devices will be followed up for 3 years to collect data.


Inclusion Criteria

Inclusion criteria includes, but may not be limited to, the following:

  • 20 years or older
  • history of recurrent symptomatic Paroxysmal Atrial Fibrillation
  • eligible for an ablation procedure

To participate:

Please contact Kristen Cornell, RN, Network Office of Research and Innovation at 610-402-9543.

Doctor(s) Running This Study